- Home
- DSGN vs SNBR Comparison
DSGN vs SNBR Comparison
Compare DSGN & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- SNBR
- Stock Information
- Founded
- DSGN 2017
- SNBR 1987
- Country
- DSGN United States
- SNBR United States
- Employees
- DSGN N/A
- SNBR N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- SNBR Home Furnishings
- Sector
- DSGN Health Care
- SNBR Consumer Discretionary
- Exchange
- DSGN Nasdaq
- SNBR Nasdaq
- Market Cap
- DSGN 208.9M
- SNBR 213.8M
- IPO Year
- DSGN 2021
- SNBR 1998
- Fundamental
- Price
- DSGN $6.03
- SNBR $9.38
- Analyst Decision
- DSGN
- SNBR Hold
- Analyst Count
- DSGN 0
- SNBR 2
- Target Price
- DSGN N/A
- SNBR $9.00
- AVG Volume (30 Days)
- DSGN 171.5K
- SNBR 585.5K
- Earning Date
- DSGN 11-06-2025
- SNBR 10-29-2025
- Dividend Yield
- DSGN N/A
- SNBR N/A
- EPS Growth
- DSGN N/A
- SNBR N/A
- EPS
- DSGN N/A
- SNBR N/A
- Revenue
- DSGN N/A
- SNBR $1,524,620,000.00
- Revenue This Year
- DSGN N/A
- SNBR N/A
- Revenue Next Year
- DSGN N/A
- SNBR N/A
- P/E Ratio
- DSGN N/A
- SNBR N/A
- Revenue Growth
- DSGN N/A
- SNBR N/A
- 52 Week Low
- DSGN $2.60
- SNBR $4.48
- 52 Week High
- DSGN $7.77
- SNBR $20.75
- Technical
- Relative Strength Index (RSI)
- DSGN 58.00
- SNBR 47.03
- Support Level
- DSGN $5.65
- SNBR $9.21
- Resistance Level
- DSGN $6.65
- SNBR $10.57
- Average True Range (ATR)
- DSGN 0.51
- SNBR 0.70
- MACD
- DSGN -0.00
- SNBR -0.17
- Stochastic Oscillator
- DSGN 64.27
- SNBR 13.47
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.